NASDAQ:BHST
BioHarvest Sciences Inc.
BioHarvest Sciences Inc.'s revenue grew 37.0% in fiscal 2025 to $34.5M while operating margin rose to −16.2%, its highest in 3 years. Free cash flow was −$9.6M, −27.8% of revenue.Summary generated from BioHarvest Sciences Inc.'s SEC filings. Latest annual report filed Mar 31, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$34.5M
Revenue growth+37.0%
Revenue, 5-yr CAGRn/a
Gross margin59.3%
Operating margin−16.2%
Net margin−32.3%
ROIC−162.6%
Return on equity−83.2%
Debt / equity0.01
Free cash flow−$9.6M
FCF margin−27.8%
Share count changen/a
Financials
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 13 | 25 | 35 |
| Operating income | −10 | −7 | −6 |
| Net income | −13 | −13 | −11 |
| Free cash flow | −10 | −10 | −10 |
Recent filings
- 6-KCurrent report (foreign issuer)
Oct 8, 2026 - 6-KCurrent report (foreign issuer)
Oct 2, 2026 - 6-KCurrent report (foreign issuer)
Sep 15, 2026 - 6-KCurrent report (foreign issuer)
Sep 15, 2026 - 6-KCurrent report (foreign issuer)
Sep 14, 2026 - 6-KCurrent report (foreign issuer)
Sep 3, 2026 - 6-KCurrent report (foreign issuer)
Aug 12, 2026 - 6-KCurrent report (foreign issuer)
Aug 11, 2026